For PTGS1 rs3842787, NSAID users homozygous for the major allele (CC) demonstrated a significantly decreased cancer risk compared with non-NSAID users (Fig. 2A, OR = 0.73, 95% CI = 0.59–0.89). Here, PTGS1 is linked to cancer.